Zongertinib shows major impact on HER2 lung cancer
Independent - 17-Oct-2025Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
Join the club for FREE to access the whole archive and other member benefits.
Consultant Thoracic Medical Oncologist at The Royal Marsden Hospital
Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research. Internationally recognized for his expertise in lung cancer, mesothelioma, and thymic malignancies, he focuses on developing targeted therapies and advancing precision medicine through clinical trials.
He chairs the British Thoracic Oncology Group (BTOG) and serves as Co-Director of the NIHR London South Clinical Research Network Cancer Division. Additionally, he is active in several international research organizations, including the European Thoracic Oncology Platform (ETOP) and the European Organisation for Research and Treatment of Cancer (EORTC).
Visit website: https://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/consultant-directory/professor-sanjay-popat
See also
Hospital dedicated to cancer diagnosis, treatment, research and education
Details last updated 03-Jun-2025
Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
New liquid biopsy accelerates targeted cancer treatment